Tourmaline Bio Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Sandeep Kulkarni
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 2.8% |
Management average tenure | less than a year |
Board average tenure | no data |
Recent management updates
CEO
Sandeep Kulkarni (41 yo)
no data
Tenure
Dr. Sandeep C. Kulkarni, M.D. was Chief Operating Officer of Immunovant, Inc. He serves as Co-Founder, CEO and Director at Tourmaline Bio, Inc. From July to October 2018, he served as Vice President, Speci...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | no data | no data | 2.85% $ 11.6m | |
VP of Finance | less than a year | no data | no data | |
Chief Technology Officer | no data | no data | 0.089% $ 363.3k | |
Chief Business Officer | no data | no data | 0.27% $ 1.1m | |
Vice President of People | no data | no data | no data | |
Chief Medical Officer | no data | no data | 0.22% $ 900.3k | |
SVP of Product Development | no data | no data | no data | |
Chief Regulatory Officer | no data | no data | 0.23% $ 916.1k | |
Senior Vice President & Head of Quality | no data | no data | no data | |
Senior VP and Head of Commercial & Business Development | less than a year | no data | no data | |
Senior Vice President of Medical Research | no data | no data | no data | |
VP & TA Head of Ophthalmology | less than a year | no data | no data |
0.7yrs
Average Tenure
52.5yo
Average Age
Experienced Management: TRML's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.